IEOHX | RGAGX | IEOHX / RGAGX | |
Total Expense Ratio | 0.67 | 0.30 | 223% |
Annual Report Gross Expense Ratio | 0.71 | 0.30 | 237% |
Fund Existence | 20 years | 16 years | - |
Gain YTD | 1.035 | 17.733 | 6% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.41B | 337B | 1% |
Annual Yield % from dividends | 0.00 | 0.59 | - |
Returns for 1 year | 8.61 | 13.24 | 65% |
Returns for 3 years | 86.81 | 74.37 | 117% |
Returns for 5 years | -6.64 | 49.92 | -13% |
Returns for 10 years | 10.09 | 118.54 | 9% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BPSCX | 26.30 | 0.18 | +0.69% |
Boston Partners Small Cap Value II Inv | |||
NUGAX | 37.28 | 0.21 | +0.57% |
Nuveen Global Dividend Growth A | |||
LMOFX | 47.49 | 0.24 | +0.51% |
Patient Opportunity FI | |||
GGRCX | 16.94 | 0.06 | +0.36% |
Goldman Sachs Strategic Growth C | |||
HGOSX | 74.13 | 0.24 | +0.32% |
Hartford Growth Opportunities R4 |